Compare Medpace Holdings Inc (MEDP) vs Vanguard Ultra Short Bond ETF (VUSB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vanguard Ultra Short Bond ETF — how do they compare? Medpace Holdings Inc trades at $598.73 (market cap $16.90B), while Vanguard Ultra Short Bond ETF trades at $49.7. The key difference: Medpace Holdings Inc is trading nearer its 52-week high, Vanguard Ultra Short Bond ETF nearer its low. Which is the better fit depends on your goals.
| MEDP | VUSB | |
|---|---|---|
Market Cap | $16.90B | — |
Sector | Technology | Leveraged / Inverse |
52-Week High | $620.59 | $50.03 |
52-Week Low | $393.42 | $49.60 |
Enterprise Value | $16.52B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
VUSB trades at $49.695, up 0.07% on the day, with a bearish technical outlook indicated by moving averages and ADX signals. Recent news highlights short-term bond ETF appeal amid potential Fed rate hikes. Financial ratios are unavailable, but the fund maintains consistent dividend distributions, with recent payouts around $0.17-$0.18 per share.
The outlook is cautious due to bearish technicals and interest rate sensitivity. Opportunities lie in short-term bond stability if rates rise, but risks include Fed policy shifts and market volatility. Investors should weigh dividend consistency against broader fixed-income pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vanguard Ultra Short Bond ETF
VUSB is an actively managed ETF from Vanguard that invests in a diversified portfolio of high-quality, investment-grade fixed income securities with maturities typically under two years. It is designed to offer higher yield potential than traditional money market funds while maintaining limited price volatility, making it a strategic tool for managing short-term reserves with a 6-to-18-month horizon.
Read more on VUSB →
